Latest News and Press Releases
Want to stay updated on the latest news?
-
MONTRÉAL, QUÉBEC--(Marketwired - 19 déc. 2016) - Thérapeutique Knight inc. (TSX:GUD) (« Knight »), société pharmaceutique...
-
MONTREAL, QUEBEC--(Marketwired - Dec. 19, 2016) - Knight Therapeutics Inc. ("Knight") (TSX:GUD), a leading Canadian specialty pharmaceutical company, announced today that it invested...
-
MONTRÉAL, QUÉBEC--(Marketwired - 15 déc. 2016) - Thérapeutique Knight inc. (TSX:GUD) (« Knight »), société pharmaceutique...
-
MONTREAL, QUEBEC--(Marketwired - Dec. 15, 2016) - Knight Therapeutics Inc. (TSX:GUD) ("Knight"), a leading Canadian specialty pharmaceutical company today announced the signing of an...
-
MONTRÉAL, QUÉBEC--(Marketwired - 10 nov. 2016) - Thérapeutique Knight inc. (TSX:GUD) (« Knight » ou la « Société »),...
-
MONTREAL, QUEBEC--(Marketwired - Nov. 9, 2016) - Knight Therapeutics Inc. (TSX:GUD) ("Knight" or the "Company"), a leading Canadian specialty pharmaceutical company, today reported...
-
MONTREAL, QUEBEC--(Marketwired - 19 sept. 2016) - Thérapeutique Knight inc. (TSX:GUD) (« Knight »), société pharmaceutique spécialisée et chef de file...
-
MONTREAL, QUEBEC--(Marketwired - Sept. 19, 2016) - Knight Therapeutics Inc. (TSX:GUD) ("Knight"), a leading Canadian specialty pharmaceutical company, announced today that Jeffrey...
-
MONTRÉAL, QUÉBEC--(Marketwired - 9 sept. 2016) - Thérapeutique Knight inc. (TSX:GUD) (« Knight »), société pharmaceutique...
-
MONTREAL, QUEBEC--(Marketwired - Sept. 9, 2016) - Knight Therapeutics Inc. ("Knight")(TSX:GUD), a leading Canadian specialty pharmaceutical company, announced today that it has closed on...